The Journal of Practical Medicine >

2023 , Vol. 39 >Issue 21: 2693 - 2697

DOI: https://doi.org/10.3969/j.issn.1006-5725.2023.21.001

Comments

Song Emphasis on standardized clinical treatment of recurrent implant failure

  • Song QUAN ,
  • Zhe. WANG
Expand
  • Center for Reproductive Medicine. Department of Obstetrics and Gynecology，Nanfang Hospital，Southern Medical University，Guangzhou 510515，China

Received date: 2023-09-06

  Online published: 2023-12-19

Fold

Abstract

Recurrent implantation failure （RIF） refers to the situation where couples facing infertility undergo multiple IVF-ET cycles and transfer multiple high-quality embryos， yet are unable to achieve embryo implantation or clinical pregnancy. The causes of RIF are multifaceted and can be influenced by many factors that may impact the outcome of IVF-ET assisted pregnancy. Despite this， there is ongoing debate regarding the definition of RIF， as well as the screening， diagnosis， and treatment approaches. This confusion largely stems from differences between current domestic and foreign guidelines and consensus. In order to provide clarity on this issue， this article aims to offer reference opinions on the standardized clinical diagnosis and treatment of RIF， based on recent research progress as well as both domestic and foreign guidelines and consensus.

Key words： recurrent implantation failure; diagnosis and treatment; guidelines; consensus

Cite this article

Song QUAN , Zhe. WANG . Song Emphasis on standardized clinical treatment of recurrent implant failure[J]. The Journal of Practical Medicine, 2023 , 39(21) : 2693 -2697 . DOI: 10.3969/j.issn.1006-5725.2023.21.001

References

1 WEI D， LIU J Y， SUN Y， et al. Frozen versus fresh single blastocyst transfer in ovulatory women： a multicentre， randomised controlled trial ［J］. Lancet， 2019， 393（10178）： 1310-1318.
2 COUGHLAN C， LEDGER W， WANG Q， et al. Recurrent implantation failure： definition and management ［J］. Reprod Biomed Online， 2014， 28（1）： 14-38.
3 中国医师协会生殖医学专业委员会，中国女医师协会生殖医学专业委员会. 反复种植失败临床诊治中国专家共识 ［J］. 中华医学杂志， 2023， 103（2）： 89-100.
4 全松， 刘婧. 反复种植失败的定义及影响因素 ［J］. 实用妇产科杂志， 2018， 34（5）： 321-324.
5 ESHRE Working Group on Recurrent Implantation Failure， CIMADOMO D， DE LOS SANTOS M J， et al. ESHRE good practice recommendations on recurrent implantation failure ［J］. Hum Reprod Open， 2023， 2023（3）： hoad023.
6 CAO H， YOU D， YUAN M， et al. Hysteroscopy after repeated implantation failure of assisted reproductive technology： A meta-analysis ［J］. J Obstet Gynaecol Res， 2018， 44（3）： 365-373.
7 EL-TOUKHY T， CAMPO R， KHALAF Y， et al. Hysteroscopy in recurrent in-vitro fertilisation failure （TROPHY）： a multicentre， randomised controlled trial ［J］. Lancet， 2016， 387（10038）： 2614-2621.
8 MAHAJAN N. Endometrial receptivity array： Clinical application ［J］. J Hum Reprod Sci， 2015， 8（3）： 121-129.
9 HASHIMOTO T， KOIZUMI M， DOSHIDA M， et al. Efficacy of the endometrial receptivity array for repeated implantation failure in Japan： A retrospective， two-centers study ［J］. Reprod Med Biol， 2017， 16（3）： 290-296.
10 HE A， ZOU Y， WAN C， et al. The role of transcriptomic biomarkers of endometrial receptivity in personalized embryo transfer for patients with repeated implantation failure ［J］. J Transl Med， 2021， 19（1）： 176.
11 COZZOLINO M， DIAZ-GIMENO P， PELLICER A， et al. Evaluation of the endometrial receptivity assay and the preimplantation genetic test for aneuploidy in overcoming recurrent implantation failure ［J］. J Assist Reprod Genet， 2020， 37（12）： 2989-2997.
12 SHAULOV T， SIERRA S， SYLVESTRE C. Recurrent implantation failure in IVF： A Canadian Fertility and Andrology Society Clinical Practice Guideline ［J］. Reprod Biomed Online， 2020， 41（5）： 819-833.
13 BELLVER J， MARIN C， LATHI R B， et al. Obesity Affects Endometrial Receptivity by Displacing the Window of Implantation ［J］. Reprod Sci， 2021， 28（11）： 3171-3180.
14 MAHAJAN N， KAUR S， ALONSO M R. Window of Implantation is Significantly Displaced in Patients with Adenomyosis with Previous Implantation Failure as Determined by Endometrial Receptivity Assay ［J］. J Hum Reprod Sci， 2018， 11（4）： 353-358.
15 KURODA K， HORIKAWA T， MORIYAMA A， et al. Impact of chronic endometritis on endometrial receptivity analysis results and pregnancy outcomes ［J］. Immun Inflamm Dis， 2020， 8（4）： 650-658.
16 LI Y， YU S， HUANG C， et al. Evaluation of peripheral and uterine immune status of chronic endometritis in patients with recurrent reproductive failure ［J］. Fertil Steril， 2020， 113（1）： 187-196 e181.
17 VITAGLIANO A， LAGANA A S， DE ZIEGLER D， et al. Chronic Endometritis in Infertile Women： Impact of Untreated Disease， Plasma Cell Count and Antibiotic Therapy on IVF Outcome-A Systematic Review and Meta-Analysis ［J］. Diagnostics （Basel）， 2022， 12（9）：2250.
18 CHENG X， HUANG Z， XIAO Z， et al. Does antibiotic therapy for chronic endometritis improve clinical outcomes of patients with recurrent implantation failure in subsequent IVF cycles？ A systematic review and meta-analysis ［J］. J Assist Reprod Genet， 2022， 39（8）： 1797-1813.
19 KATO H， YAMAGISHI Y， HAGIHARA M， et al. Systematic review and meta-analysis for impacts of oral antibiotic treatment on pregnancy outcomes in chronic endometritis patients ［J］. J Infect Chemother， 2022， 28（5）： 610-615.
20 MORENO I， GARCIA-GRAU I， PEREZ-VILLAROYA D， et al. Endometrial microbiota composition is associated with reproductive outcome in infertile patients ［J］. Microbiome， 2022， 10（1）： 1.
21 MASCARENHAS M， JEVE Y， POLANSKI L， et al. Management of recurrent implantation failure： British Fertility Society policy and practice guideline ［J］. Hum Fertil （Camb）， 2022， 25（5）： 813-837.
22 ANDREOLI L， BERTSIAS G K， AGMON-LEVIN N， et al. EULAR recommendations for women's health and the management of family planning， assisted reproduction， pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome ［J］. Ann Rheum Dis， 2017， 76（3）： 476-485.
23 COUGHLAN C， YUAN X， NAFEE T， et al. The clinical characteristics of women with recurrent implantation failure ［J］. J Obstet Gynaecol， 2013， 33（5）： 494-498.
24 ESHRE GUIDELINE GROUP ON RPL， BENDER ATIK R， CHRISTIANSEN O B， et al. ESHRE guideline： recurrent pregnancy loss ［J］. Hum Reprod Open， 2018， 2018（2）： hoy004.
25 ALEXANDER E K， PEARCE E N， BRENT G A， et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum ［J］. Thyroid， 2017， 27（3）： 315-389.
26 SATO T， SUGIURA-OGASAWARA M， OZAWA F， et al. Preimplantation genetic testing for aneuploidy： a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure ［J］. Hum Reprod， 2019， 34（12）： 2340-2348.
27 徐晨明. 胚胎植入前遗传学诊断/筛查技术专家共识 ［J］. 中国产前诊断杂志（电子版）， 2018， 10（2）： 57.
28 CIMADOMO D， CAPALBO A， DOVERE L， et al. Leave the past behind： women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers ［J］. Hum Reprod， 2021， 36（4）： 929-940.
29 GENEST G， BANJAR S， ALMASRI W， et al. Immunomodulation for unexplained recurrent implantation failure： where are we now？ ［J］. Reproduction， 2023， 165（2）： R39-R60.
30 张曦倩， 许虹， 罗燕群， 等. 宫腔灌注粒细胞刺激因子对反复种植失败患者妊娠结局及免疫状态的影响 ［J］. 实用医学杂志， 2020， 36（13）： 1770-1773.
31 王梓骅， 任春娥， 任文超， 等. 宫腔内灌注地塞米松对胚胎反复种植失败患者的疗效 ［J］. 实用医学杂志， 2021， 37（08）： 1064-1067.
32 姚元庆， 王辉. 反复种植失败的子宫内膜因素及对策 ［J］. 实用妇产科杂志， 2018， 34（5）： 326-328.
33 ABDOLMOHAMMADI-VAHID S， PASHAZADEH F， POURMOGHADDAM Z， et al. The effectiveness of IVIG therapy in pregnancy and live birth rate of women with recurrent implantation failure （RIF）： A systematic review and meta-analysis ［J］. J Reprod Immunol， 2019， 134-135： 28-33.
34 ATA B， URMAN B. Thrombophilia and assisted reproduction technology-any detrimental impact or unnecessary overuse？ ［J］. J Assist Reprod Genet， 2016， 33（10）： 1305-1310.
35 POTDAR N， GELBAYA T A， KONJE J C， et al. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure： a systematic review and meta-analysis ［J］. Hum Reprod Update， 2013， 19（6）： 674-684.
36 SIRISTATIDIS C， DAFOPOULOS K， SALAMALEKIS G， et al. Administration of low-molecular-weight heparin in patients with two or more unsuccessful IVF/ICSI cycles： a multicenter cohort study ［J］. Gynecol Endocrinol， 2018， 34（9）： 747-751.
37 KALAMPOKAS T， PANDIAN Z， KEAY S D， et al. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI ［J］. The Cochrane database of systematic reviews， 2017， 3： CD004752.
38 BOOMSMA C M， KAMATH M S， KEAY S D， et al. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles ［J］. Cochrane Database Syst Rev， 2022， 6（6）： CD005996.
39 SUN Y， CUI L， LU Y， et al. Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization： A Randomized Clinical Trial ［J］. JAMA， 2023， 329（17）： 1460-1468.
Options
Outlines

/

〈 〉